
Tonix Pharmaceuticals to Present at March Investor Conferences Amid Key Product Developments
Tonix Pharmaceuticals will participate in two major investor conferences in March 2026, highlighting its commercial-stage biotechnology portfolio focused on CNS and immunology treatments with significant unmet medical needs.
Read full story

























